REG-BARCLAYS PLC Form 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
12/10/2015 15:21
http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20151012:nBw125722a
http://www.businesswire.com/news/home/20151012005722/en
LONDON--(Business Wire)--
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose STERIS CORPORATION
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 09 October 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SYNERGY HEALTH PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2(a)
or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 2,903 0.00% 286,611 0.48%
(2) Cash-settled derivatives:
284,112 0.47% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 287,015 0.48% 286,611 0.48%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be given
on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors` and other
employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of
the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 15 66.5900 USD
ORD Purchase 100 66.8950 USD
ORD Purchase 100 66.6300 USD
ORD Purchase 200 66.5050 USD
ORD Purchase 200 66.6250 USD
ORD Purchase 200 66.6200 USD
ORD Purchase 300 66.5983 USD
ORD Purchase 316 67.3855 USD
ORD Purchase 630 66.6324 USD
ORD Purchase 700 66.4414 USD
ORD Purchase 745 66.6400 USD
ORD Purchase 930 66.9242 USD
ORD Purchase 1,100 66.8626 USD
ORD Purchase 1,303 66.8625 USD
ORD Purchase 1,400 66.6218 USD
ORD Purchase 1,560 66.8115 USD
ORD Purchase 1,782 66.8006 USD
ORD Purchase 1,863 66.8321 USD
ORD Purchase 2,695 66.6040 USD
ORD Purchase 5,200 66.6238 USD
ORD Purchase 5,605 66.7308 USD
ORD Purchase 6,500 66.7950 USD
ORD Purchase 8,800 66.7316 USD
ORD Purchase 12,440 66.6473 USD
ORD Sale 7 67.0700 USD
ORD Sale 56 67.4000 USD
ORD Sale 100 66.5800 USD
ORD Sale 114 66.6475 USD
ORD Sale 192 66.5297 USD
ORD Sale 193 67.0600 USD
ORD Sale 200 66.6225 USD
ORD Sale 200 66.6150 USD
ORD Sale 244 66.7515 USD
ORD Sale 262 67.2870 USD
ORD Sale 316 67.3855 USD
ORD Sale 400 66.6325 USD
ORD Sale 500 66.6620 USD
ORD Sale 1,000 66.7715 USD
ORD Sale 1,137 66.7546 USD
ORD Sale 1,200 66.7829 USD
ORD Sale 1,200 66.5958 USD
ORD Sale 1,260 66.6324 USD
ORD Sale 4,900 66.7172 USD
ORD Sale 5,100 66.7196 USD
ORD Sale 5,300 66.7977 USD
ORD Sale 6,220 66.7045 USD
ORD Sale 6,220 66.6473 USD
ORD Sale 7,178 66.8405 USD
ORD Sale 11,185 66.6341 USD
(b) Cash-settled derivative transactions
Class of relevant security Product description Nature of dealing Number of reference securities Price per unit
e.g. CFD e.g. opening/closing a long/short position, increasing/reducing a long/short position
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the person making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 12 Oct 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service and must also be emailed to the Takeover Panel at
monitoring@disclosure.org.uk. The Panel`s Market Surveillance Unit is available
for consultation in relation to the Code`s disclosure requirements on +44 (0)20
7638 0129.
The Code can be viewed on the Panel`s website at www.thetakeoverpanel.org.uk.
View source version on businesswire.com:
http://www.businesswire.com/news/home/20151012005722/en/
BARCLAYS PLC
Copyright Business Wire 2015Recent news on Steris
See all newsREG - Travelex Financing - Update on debt restructuring
AnnouncementREG - Synergy Health Steris Corp. - Scheme Effective <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - State Street Global Steris Corp. Synergy Health - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - Legal&Gen Inv Mgmnt Synergy Health Steris Corp. - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Announcement